Pomalidomide Myeloma Trials

SparkCures ID	5
Developed By	Celgene Corporation, a wholly owned subsidiary of Bristol Myers Squibb
Brand Name	Pomalyst^®
Generic Name	Pomalidomide
Additional Names	CC-4047, Actimid
Treatment Classifications	Immunomodulatory Drug (IMiD)

All Clinical Trials

View all active clinical trials around the US.

Verified

Phase 3 Clinical Trial Evaluating the Safety and Effectiveness of Investigational Drug Mezigdomide in Combination with Bortezomib and Dexamethasone Compared ...

SUCCESSOR-1

View Trial

Verified

Phase 3 Clinical Trial Comparing the Safety and Efficacy of BMS-986393 to Standard of Care Regimens in Patients with Relapsed/Refractory Multiple Myeloma

QUINTESSENTIAL-2

View Trial

Verified

Phase 3 Clinical Trial Comparing the Safety and Effectiveness of Elranatamab Versus Commonly Used Combination Regimens in Participants with Relapsed/Refracto...

MAGNETISMM-32

View Trial

Verified

Phase 3 Clinical Trial Comparing a Study Medication Alone Versus Pomalidomide, Bortezomib, Dexamethasone or Carfilzomib and Dexamethasone in Patients with Re...

MAJESTEC-9

View Trial

Verified

Phase 1B / 2 Study of Selinexor in Combination With Other Treatments for Relapsed/Refractory and Newly Diagnosed Multiple Myeloma.

STOMP

View Trial

Verified

A Phase 3 Randomized Study Comparing Talquetamab in Combination With Pomalidomide (Tal-P), Talquetamab in Combination With Teclistamab (Tal-Tec), and Investi...

MONUMENTAL-6

View Trial

Verified

Phase 3 Clinical Trial Comparing the Safety and Effectiveness of Selinexor, Pomalidomide and Dexamethasone vs Elotuzumab, Pomalidomide and Dexamethasone in R...

SELINEXOR

View Trial

Verified

Daratumumab, Carfilzomib, Pomalidomide, Dexamethasone In MM

DARATUMUMAB COMBINATION THERAPY

View Trial

SparkCures Verified Accurate, up-to-date information. Learn more

A Phase 3, Randomized, Open-Label Study to Compare the Efficacy and Safety of Anitocabtagene Autoleucel Ver...

IMMAGINE-3

View Trial

A Phase 3, Multicenter, Randomized, Open Label Study of Etentamig Compared With Standard Available Therapie...

CERVINO

View Trial

Phase II Study of Belantamab Mafodotin in Combination With Carfilzomib, Pomalidomide, and Dexamethasone (KP...

BELANTAMAB MAFODOTIN

View Trial

A Study of Selinexor, in Combination With Carfilzomib, Daratumumab or Pomalidomide in Patients With Multipl...

SELINEXOR

View Trial

Leflunomide, Pomalidomide, and Dexamethasone for the Treatment of Relapsed or Refractory Multiple Myeloma

LEFLUNOMIDE

View Trial

A Phase II Study of ISABELA: Isatuximab, Belantamab Mafodotin, Pomalidomide, and Dexamethasone in Relapsed ...

ISABELA

View Trial

Isatuximab, Pomalidomide, Elotuzumab and Dexamethasone in Relapsed and/or Refractory Multiple Myeloma

IMPEDE

View Trial

A Phase II Study of Daratumumab, Clarithromycin, Pomalidomide And Dexamethasone (D-ClaPd) In Multiple Myelo...

D-CLAPD

View Trial

Belantamab Mafodotin, Pomalidomide and Dexamethasone for the Treatment of High-Risk Myeloma

BELANTAMAB MAFODOTIN COMBINATION THERAPY

View Trial

Isatuximab, Carfilzomib, Pomalidomide, and Dexamethasone for the Treatment of Relapsed or Refractory Multip...

ISA-CAPED

View Trial

A Study of an MMSET Inhibitor in Patients With Relapsed and Refractory Multiple Myeloma

MMSET INHIBITOR

View Trial

Study to Evaluate CCS1477 (inobrodib) in Haematological Malignancies

INOBRODIB

View Trial

A Phase 1b/2 Study of Sonrotoclax (BGB-11417) as Monotherapy and in Various Combinations With Dexamethasone...

SONROTOCLAX (BGB-11417)

View Trial

Phase 1-2 UMBRELLA Trial Evaluating Isatuximab With or Without Dexamethasone in Combination With Novel Agen...

ISATUXIMAB IN COMBINATION WITH NOVEL AGENTS

View Trial

A Study to Assess Adverse Events and Change in Disease Activity of Intravenously (IV) Infused ABBV-383 in C...

ETENTAMIG

View Trial

A Study to Examine the Effects of Novel Therapy Linvoseltamab in Combination With Other Cancer Treatments f...

LINVOSELTAMAB

View Trial

APG-2575 in Combination With Novel Therapeutic Regimens in Subjects With Relapsed or Refractory Multiple My...

APG-2575

View Trial

Early Relapse Multiple Myeloma

The following is a listing of clinical trials for patients with multiple myeloma who have received one to two prior lines of therapy.

Verified

Phase 3 Clinical Trial Evaluating the Safety and Effectiveness of Investigational Drug Mezigdomide in Combination with Bortezomib and Dexamethasone Compared ...

SUCCESSOR-1

View Trial

Verified

Phase 3 Clinical Trial Comparing the Safety and Efficacy of BMS-986393 to Standard of Care Regimens in Patients with Relapsed/Refractory Multiple Myeloma

QUINTESSENTIAL-2

View Trial

Verified

Phase 3 Clinical Trial Comparing the Safety and Effectiveness of Elranatamab Versus Commonly Used Combination Regimens in Participants with Relapsed/Refracto...

MAGNETISMM-32

View Trial

Verified

Phase 1B / 2 Study of Selinexor in Combination With Other Treatments for Relapsed/Refractory and Newly Diagnosed Multiple Myeloma.

STOMP

View Trial

Verified

A Phase 3 Randomized Study Comparing Talquetamab in Combination With Pomalidomide (Tal-P), Talquetamab in Combination With Teclistamab (Tal-Tec), and Investi...

MONUMENTAL-6

View Trial

Verified

Phase 3 Clinical Trial Comparing the Safety and Effectiveness of Selinexor, Pomalidomide and Dexamethasone vs Elotuzumab, Pomalidomide and Dexamethasone in R...

SELINEXOR

View Trial

Verified

Daratumumab, Carfilzomib, Pomalidomide, Dexamethasone In MM

DARATUMUMAB COMBINATION THERAPY

View Trial

SparkCures Verified Accurate, up-to-date information. Learn more

A Phase 3, Randomized, Open-Label Study to Compare the Efficacy and Safety of Anitocabtagene Autoleucel Ver...

IMMAGINE-3

View Trial

A Phase 3, Multicenter, Randomized, Open Label Study of Etentamig Compared With Standard Available Therapie...

CERVINO

View Trial

Phase II Study of Belantamab Mafodotin in Combination With Carfilzomib, Pomalidomide, and Dexamethasone (KP...

BELANTAMAB MAFODOTIN

View Trial

A Study of Selinexor, in Combination With Carfilzomib, Daratumumab or Pomalidomide in Patients With Multipl...

SELINEXOR

View Trial

Leflunomide, Pomalidomide, and Dexamethasone for the Treatment of Relapsed or Refractory Multiple Myeloma

LEFLUNOMIDE

View Trial

A Phase II Study of ISABELA: Isatuximab, Belantamab Mafodotin, Pomalidomide, and Dexamethasone in Relapsed ...

ISABELA

View Trial

Isatuximab, Pomalidomide, Elotuzumab and Dexamethasone in Relapsed and/or Refractory Multiple Myeloma

IMPEDE

View Trial

A Phase II Study of Daratumumab, Clarithromycin, Pomalidomide And Dexamethasone (D-ClaPd) In Multiple Myelo...

D-CLAPD

View Trial

Isatuximab, Carfilzomib, Pomalidomide, and Dexamethasone for the Treatment of Relapsed or Refractory Multip...

ISA-CAPED

View Trial

Study to Evaluate CCS1477 (inobrodib) in Haematological Malignancies

INOBRODIB

View Trial

A Phase 1b/2 Study of Sonrotoclax (BGB-11417) as Monotherapy and in Various Combinations With Dexamethasone...

SONROTOCLAX (BGB-11417)

View Trial

Phase 1-2 UMBRELLA Trial Evaluating Isatuximab With or Without Dexamethasone in Combination With Novel Agen...

ISATUXIMAB IN COMBINATION WITH NOVEL AGENTS

View Trial

A Study to Examine the Effects of Novel Therapy Linvoseltamab in Combination With Other Cancer Treatments f...

LINVOSELTAMAB

View Trial

APG-2575 in Combination With Novel Therapeutic Regimens in Subjects With Relapsed or Refractory Multiple My...

APG-2575

View Trial

Late Relapse Multiple Myeloma

The following is a listing of clinical trials for patients with multiple myeloma who have received three or more prior lines of therapy.

Verified

Phase 3 Clinical Trial Evaluating the Safety and Effectiveness of Investigational Drug Mezigdomide in Combination with Bortezomib and Dexamethasone Compared ...

SUCCESSOR-1

View Trial

Verified

Phase 3 Clinical Trial Comparing the Safety and Efficacy of BMS-986393 to Standard of Care Regimens in Patients with Relapsed/Refractory Multiple Myeloma

QUINTESSENTIAL-2

View Trial

Verified

Phase 3 Clinical Trial Comparing the Safety and Effectiveness of Elranatamab Versus Commonly Used Combination Regimens in Participants with Relapsed/Refracto...

MAGNETISMM-32

View Trial

Verified

Phase 1B / 2 Study of Selinexor in Combination With Other Treatments for Relapsed/Refractory and Newly Diagnosed Multiple Myeloma.

STOMP

View Trial

Verified

A Phase 3 Randomized Study Comparing Talquetamab in Combination With Pomalidomide (Tal-P), Talquetamab in Combination With Teclistamab (Tal-Tec), and Investi...

MONUMENTAL-6

View Trial

Verified

Phase 3 Clinical Trial Comparing the Safety and Effectiveness of Selinexor, Pomalidomide and Dexamethasone vs Elotuzumab, Pomalidomide and Dexamethasone in R...

SELINEXOR

View Trial

Verified

Daratumumab, Carfilzomib, Pomalidomide, Dexamethasone In MM

DARATUMUMAB COMBINATION THERAPY

View Trial

SparkCures Verified Accurate, up-to-date information. Learn more

A Phase 3, Randomized, Open-Label Study to Compare the Efficacy and Safety of Anitocabtagene Autoleucel Ver...

IMMAGINE-3

View Trial

A Phase 3, Multicenter, Randomized, Open Label Study of Etentamig Compared With Standard Available Therapie...

CERVINO

View Trial

Phase II Study of Belantamab Mafodotin in Combination With Carfilzomib, Pomalidomide, and Dexamethasone (KP...

BELANTAMAB MAFODOTIN

View Trial

A Study of Selinexor, in Combination With Carfilzomib, Daratumumab or Pomalidomide in Patients With Multipl...

SELINEXOR

View Trial

Leflunomide, Pomalidomide, and Dexamethasone for the Treatment of Relapsed or Refractory Multiple Myeloma

LEFLUNOMIDE

View Trial

A Phase II Study of ISABELA: Isatuximab, Belantamab Mafodotin, Pomalidomide, and Dexamethasone in Relapsed ...

ISABELA

View Trial

Isatuximab, Pomalidomide, Elotuzumab and Dexamethasone in Relapsed and/or Refractory Multiple Myeloma

IMPEDE

View Trial

A Phase II Study of Daratumumab, Clarithromycin, Pomalidomide And Dexamethasone (D-ClaPd) In Multiple Myelo...

D-CLAPD

View Trial

Isatuximab, Carfilzomib, Pomalidomide, and Dexamethasone for the Treatment of Relapsed or Refractory Multip...

ISA-CAPED

View Trial

A Study of an MMSET Inhibitor in Patients With Relapsed and Refractory Multiple Myeloma

MMSET INHIBITOR

View Trial

Study to Evaluate CCS1477 (inobrodib) in Haematological Malignancies

INOBRODIB

View Trial

A Phase 1b/2 Study of Sonrotoclax (BGB-11417) as Monotherapy and in Various Combinations With Dexamethasone...

SONROTOCLAX (BGB-11417)

View Trial

Phase 1-2 UMBRELLA Trial Evaluating Isatuximab With or Without Dexamethasone in Combination With Novel Agen...

ISATUXIMAB IN COMBINATION WITH NOVEL AGENTS

View Trial

A Study to Examine the Effects of Novel Therapy Linvoseltamab in Combination With Other Cancer Treatments f...

LINVOSELTAMAB

View Trial

APG-2575 in Combination With Novel Therapeutic Regimens in Subjects With Relapsed or Refractory Multiple My...

APG-2575

View Trial

Smoldering Myeloma

No active clinical trials

Monoclonal Gammopathy of Undetermined Significance (MGUS)

No active clinical trials

Pomalidomide

POMALYST®

Overview

Clinical Trials

Resources

POMALYST^®